Updated 04 July 2014

Anaemia treatments don't boost brain injury recovery

Medication to boost red blood cells and blood transfusions make no difference to the outcomes of people suffering from anaemia as a result of a severe head injury.

People who suffer a severe head injury often develop anaemia, but aggressively treating the blood condition may do more harm than good, a new clinical trial suggests.

Experts said the findings, reported in the Journal of the American Medical Association, were disappointing: Treating anaemia with blood transfusions – and in some cases, the medication erythropoietin – did nothing to improve brain-injured patients' long-term recovery.

And when transfusions were used more aggressively, the risk of blood clots increased.

Lead researcher Dr. Claudia Robertson said the results "will probably change clinical practice."

Transfusion of red blood cells
Anaemia is a condition in which the body has too few oxygen-carrying red blood cells. It's common for people with serious traumatic injuries to develop anaemia, because of internal and external bleeding and other damage to the body.

In trauma victims without a brain injury, doctors normally give a transfusion of red blood cells after the patient's haemoglobin levels fall below 7 grams per decilitre (g/dL), explained Robertson, a neurosurgeon at Baylor College of Medicine in Houston.

But, she said, there has been "controversy" over what's best for brain-injured patients.

Haemoglobin is the oxygen-carrying protein in red blood cells, and a healthy person typically has a level of about 15 g/dL, Robertson noted. Doctors have worried that in patients with serious brain injuries, allowing haemoglobin to drop to 7 g/dL or lower could be harmful – so they often aim for higher levels.

"Red blood cells carry oxygen to the brain," Robertson said. "So the thinking is, more oxygen is better."

Four treatment groups
To put that theory to the test, Robertson's team followed 200 patients who landed in one of two American trauma centres with severe head injuries. Within six hours of their injury, the patients were randomly assigned to one of four treatment groups.

In two groups, patients were transfused with enough red blood cells to keep their haemoglobin level at 7 g/dL; in one of those groups, patients also received the anaemia drug erythropoietin (Epogen) – also known as "epo". Two other groups were transfused to maintain a haemoglobin level of 10 g/dL, with or without epo.

Unlike blood transfusions, epo is not a standard part of treating anaemia in critically injured patients, Robertson said. This study was set up to see whether the medication might be helpful.

In the end, it wasn't. The epo treatments did not improve patients' long-term recovery from their brain injury, Robertson's team found.

Nor did the higher haemoglobin levels: Six months later, 42.5 percent of patients in the 7 g/dL group were either back to their normal lives or had moderate disabilities. That compared with 33 percent in the 10 g/dL group.

Good question to ask
What's more, the risk of potentially fatal blood clots was greater in patients whose haemoglobin levels were kept higher.

Dr. Jaime Levine, a specialist in brain-injury rehabilitation, said that while the findings are disappointing, they're not all that surprising. Anaemia treatments, she noted, are not specifically designed to help shield brain cells from damage.

Unfortunately, there are no medications specifically designed for traumatic brain injuries, said Levine, a clinical assistant professor at NYU Langone Medical Centre in New York City.
Read: Study links traumatic brain injury to increased dementia risk

The question of whether these anaemia treatments could make a difference in patients' brain injury recovery is "valid," according to Levine. "It's a good question to ask, even if it didn't work," she said.

Study author Robertson said that as far as blood transfusions go, she thinks her team's findings are "definitive."

Bigger picture brighter
"We should manage patients with traumatic brain injury the same way we do [trauma] patients without brain injury," she said.

But Robertson noted that other researchers are still looking at the effects of epo on patients with brain injuries.

And, she noted, the bigger picture surrounding brain injury treatment is brighter. "Outcomes from traumatic brain injury have improved a lot in the past 20 years," Robertson said.

She credited that to changes in how trauma care is organized – more severely injured patients are getting to "level 1" trauma centres faster – and major advances in brain-imaging technology.

More information

The US National Institute of Neurological Disorders and Stroke has more on traumatic brain injury.

Read more:
Head injuries may eventually lead to depression
Traumatic brain Injury: what Schumi is going through




Read Health24’s Comments Policy

Comment on this story
Comments have been closed for this article.

Live healthier

Lifestyle »

E-cigarettes: Here are five things to know

E-cigarettes have become hugely popular in the past decade, but a rash of vaping-linked deaths and illnesses in the US is feeding caution about a product that's already banned in some places.

Allergy »

Ditch the itch: Researchers find new drug to fight hives

A new drug works by targeting an immune system antibody called immunoglobulin E, which is responsible for the allergic reaction that causes hives.